89Zr-Df-IAB41M2C

N/A

Report date: 2025/09/10 10:58:23

NME

Base Information

Drug Name89Zr-Df-IAB41M2C

Drug Alias Name89Zr Df IAB41M2C

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Zirconium > 89ZrRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionPositron-emission tomography enhancers

TargetsUpdating

Therapy Area/IndicationsAutoimmune DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesImaginab Inc

China Registration ClassN/A

Develop Information

Active CompaniesImaginab Inc

Inactive CompaniesN/A

Active IndicationsAutoimmune DiseasesNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A